{"transactions":[{"id":689455,"issuer":{"id":7926,"kind":"organization","name":"Adagio Medical Holdings, Inc.","symbol":"ADGM"},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-08-12T17:47:01.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"Option\"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"Option\"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026."}],"balance_after":30000,"derivative":{"exercise_price":0.7103,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001665442-26-000002","document":"form4-08122026_050857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006986/000166544226000002/form4-08122026_050857.xml","form_type":"4"}},{"id":885096,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T23:42:06.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":123000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed"}],"balance_after":405120,"source":{"system":"sec-edgar","filing":"0001094891-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000109489126000068/form4.xml","form_type":"4"}},{"id":1194825,"issuer":{"id":7926,"kind":"organization","name":"Adagio Medical Holdings, Inc.","symbol":"ADGM"},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2025-03-21T23:00:18.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":364000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock Option granted pursuant to Issuer's 2024 Equity Incentive Plan (the \"Special Option\"). Special Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Special Option is vested in full as of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option granted pursuant to Issuer's 2024 Equity Incentive Plan (the \"Special Option\"). Special Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Special Option is vested in full as of the grant date."}],"balance_after":364000,"derivative":{"exercise_price":0.865,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":364000},"source":{"system":"sec-edgar","filing":"0001415889-25-008807","document":"form4-03212025_110314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006986/000141588925008807/form4-03212025_110314.xml","form_type":"4"}},{"id":1194824,"issuer":{"id":7926,"kind":"organization","name":"Adagio Medical Holdings, Inc.","symbol":"ADGM"},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2025-03-21T23:00:18.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the \"Option\"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the \"Option\"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024."}],"balance_after":90000,"derivative":{"exercise_price":0.865,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-008807","document":"form4-03212025_110314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006986/000141588925008807/form4-03212025_110314.xml","form_type":"4"}},{"id":1253076,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:08:15.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":112800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed"}],"balance_after":282120,"source":{"system":"sec-edgar","filing":"0001062993-25-003174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299325003174/form4.xml","form_type":"4"}},{"id":1443145,"issuer":{"id":7926,"kind":"organization","name":"Adagio Medical Holdings, Inc.","symbol":"ADGM"},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-02T12:00:11.000Z","date":"2024-07-31","kind":"other","planned":false,"acquired":true,"shares":36698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination (the \"Business Combination\") contemplated by the Business Combination Agreement (the \"BCA\"), dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., \"New Adagio\" and following the completion of the Business Combination, the \"Issuer\"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. (\"Adagio\") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held by the reporting person prior to the completion of the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination (the \"Business Combination\") contemplated by the Business Combination Agreement (the \"BCA\"), dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., \"New Adagio\" and following the completion of the Business Combination, the \"Issuer\"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. (\"Adagio\") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held by the reporting person prior to the completion of the Business Combination."}],"balance_after":36698,"source":{"system":"sec-edgar","filing":"0001140361-24-035440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006986/000114036124035440/form4.xml","form_type":"4"}},{"id":1622723,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-02-23T21:46:39.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025."}],"balance_after":150000,"derivative":{"exercise_price":1.23,"expiration_date":"2034-02-22","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001062993-24-004284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299324004284/form4.xml","form_type":"4"}},{"id":1621717,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-02-23T21:41:31.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001062993-24-004277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000106299324004277/form4.xml","form_type":"4"}},{"id":2035061,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-03T01:41:08.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023."}],"balance_after":450000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-01-30","underlying":"Common stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001062993-23-002040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000106299323002040/form4.xml","form_type":"4"}},{"id":2036362,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-03T01:38:29.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023."}],"balance_after":175000,"derivative":{"exercise_price":1.31,"expiration_date":"2033-01-31","underlying":"Common stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001062993-23-002036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323002036/form4.xml","form_type":"4"}},{"id":2377248,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2022-02-24T01:19:24.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 quarterly installments, with first installment vesting March 31, 2022."}],"balance_after":80000,"derivative":{"exercise_price":1.59,"expiration_date":"2032-02-18","underlying":"Common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001062993-22-005488","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000106299322005488/form4.xml","form_type":"4"}},{"id":2378839,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2022-02-24T01:18:38.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 quarterly installments, with first installment vesting March 31, 2022."}],"balance_after":59000,"derivative":{"exercise_price":3.95,"expiration_date":"2032-02-18","underlying":"Common stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001062993-22-005487","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299322005487/form4.xml","form_type":"4"}},{"id":2756699,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-05T22:31:12.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal quarterly installments commencing on September 30, 2021."}],"balance_after":50000,"derivative":{"exercise_price":4.44,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001094891-21-000176","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489121000176/edgar.xml","form_type":"4"}},{"id":3163308,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-05-04T21:46:42.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal quarterly installments commencing on June 30, 2020."}],"balance_after":100000,"derivative":{"exercise_price":2.19,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001094891-20-000070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489120000070/edgar.xml","form_type":"4"}},{"id":3598691,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-12T12:01:46.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal quarterly installments commencing on March 31, 2019."}],"balance_after":200000,"derivative":{"exercise_price":1,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001094891-19-000089","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489119000089/edgar.xml","form_type":"4"}},{"id":4051152,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":24207,"kind":"person","name":"Cox James L","position":1,"cik":"0001665442","reported_name":"Cox James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T21:27:43.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal quarterly installments commencing on March 31, 2018."}],"balance_after":100000,"derivative":{"exercise_price":2.01,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001094891-18-000052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489118000052/edgar.xml","form_type":"4"}}]}